Allen Institute for Artificial Intelligence
supp.ai logo
supp.ai

Discover Supplement-Drug Interactions

Disclaimer: The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The tool is not a substitute for the care provided… (more)
Last Updated: 3 years ago

Possible Interaction: Inosine and Pentostatin

supplement:

Inosine

Research Papers that Mention the Interaction

High concentrations of deoxycoformycin and EHNA inhibit all pathways of purine ribonucleotide synthesis, and inhibit the conversion of inosinate to adenine and guanine nucleotides.
Biochemical pharmacology  •  1977  |  View Paper
Apparent ADA activity (as estimated by isotopic flux to inosine and hypoxanthine) was profoundly inhibited by dCF (with at least 50% inhibition at 10(-8) M and 95% inhibition at 10(-5) M dCF).
Research communications in chemical pathology and pharmacology  •  1986  |  View Paper
Pentostatin also resulted in a significant reduction in the accumulation of inosine and hypoxanthine, indicating inhibition of adenosine deaminase activity.
Basic Research in Cardiology  •  2004  |  View Paper
Inosine , hypoxanthine, and xanthine levels were depressed by deoxycoformycin.
Journal of neurochemistry  •  1991  |  View Paper
Inosine and hypoxanthine release were attenuated at the higher dose of deoxycoformycin , acid release into the cortical perfusates was enhanced at the higher dose level.
Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism  •  1988  |  View Paper
Adenosine deamination, and thus its conversion to nucleotides via inosine‐hypoxanthine‐inosine monophosphate, was inhibited by pretreatment of the cells or cell extracts with 2‐deoxycoformycin.
Journal of cellular physiology  •  1983  |  View Paper